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Abstract 
This paper aims to explore the organizational implications where market trends drive the adoption of 
service-based business models within the medical device industry and, secondarily, to establish 
frameworks for the execution of new management models. This paper represents an attempt to explore 
the emerging changes in value-driven deliverables for medical device manufacturers as new medical 
technologies fundamentally change the way providers and businesses deliver patient care. The research 
was conducted through interviews with leaders in the medical device industry, combined with examining 
academic literature related to organizational strategy and structure, to explore the implicit perspectives 
on the challenges and opportunities related to the shift from product-focused to service-oriented 
organizations. This is the first research project that specifically explores the impact of medical 
technology on device manufacturers’ business strategy shifting from selling products to selling services. 
The premise for this analysis is the thesis that large medical device manufacturers will be forced to shift 
business models from product-driven manufacturing and sales to service-oriented business. The 
strategic focus behind this fundamental shift is based on how existing implantable devices are becoming 
more commoditized and less able to differentiate through product innovation. Fundamentally, product- 
and service-based businesses operate in different capacities. This paper attempts to understand how the 
medical device business can successfully adjust, from an operational and cultural perspective, so as to 
compete in the changing healthcare environment. 
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This paper aims to explore the organizational implications where market trends 
drive the adoption of service-based business models within the medical device industry 
and, secondarily, to establish frameworks for the execution of new management models. 
This paper represents an attempt to explore the emerging changes in value-driven 
deliverables for medical device manufacturers as new medical technologies 
fundamentally change the way providers and businesses deliver patient care. The research 
was conducted through interviews with leaders in the medical device industry, combined 
with examining academic literature related to organizational strategy and structure, to 
explore the implicit perspectives on the challenges and opportunities related to the shift 
from product-focused to service-oriented organizations. This is the first research project 
that specifically explores the impact of medical technology on device manufacturers’ 
business strategy shifting from selling products to selling services. 
The premise for this analysis is the thesis that large medical device manufacturers 
will be forced to shift business models from product-driven manufacturing and sales to 
service-oriented business. The strategic focus behind this fundamental shift is based on 
how existing implantable devices are becoming more commoditized and less able to 
differentiate through product innovation. Fundamentally, product- and service-based 
businesses operate in different capacities. This paper attempts to understand how the 
medical device business can successfully adjust, from an operational and cultural 
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1.1 Premise/Hypothesis/Thesis: Sections 2–5 
The premise of this research is primarily rooted in the challenges faced by 
organizations while strategically evolving from a product-oriented business to a service-
oriented business and in how simple mental models can be applied to help frame this 
transition. The medical device sector is an industry subject to incremental innovation on 
implantable devices and instrumentation, and it is currently experiencing disruption due 
to the growing popularity of software-based solutions and, in many cases, robotic 
intervention. The introduction of this research will highlight some of my personal 
experiences within the industry as well as the background and context of many of these 
industrial changes. To better frame the issues, this research will highlight the current 
status of medical device manufacturers’ relationships with their customers and how the 
business is traditionally conducted in a relationship-based and product-driven manner. 
Focusing further on my personal experiences, Section 3 will introduce the thesis 
around the need for servitization within the industry, ultimately calling for a shift from 
product-focused manufacturing to a strategic service-oriented value chain as medical 
device companies take on the persona of “med tech” organizations. We will additionally  
introduce the concept of subject matter experts having vital roles in the suggested shift 
and further discuss the strategic business needs around digital surgery, where a 
competitive advantage can be found. Section 4 introduces servitization within the specific 
context of the medical device industry will further emphasize the need for a differentiated 





Finally, Section 5 will introduce the concept of geometric thinking, which forms 
the foundation of this research, and ultimately help reframe some of the suggested 
solutions. These mental models will continuously be applied throughout the paper to help 
better visualize complex issues in a more digestible fashion. 
1.2 How I Tested It: Sections 6–7 
The hypothesis around a need for a service shift in the medical device industry 
was tested from three perspectives to better understand the options and challenges the 
organizations will face throughout the transition. First, I drew upon my experience of 
working with both large and small medical robotics companies, reflecting on the 
associated clinical experiences and cultural observations. I worked alongside physicians 
and various industry stakeholders, and these experiences helped shape my growing 
understanding of how the industry norms are shifting and how organizations can prepare 
for these new circumstances. 
Second, I spoke with stakeholders across the field of healthcare, ranging from the 
CEOs of startup companies to manufacturing veterans with over 30 years of experience, 
all of whom qualify as subject matter experts within their field. This helped me gain a 
better understanding of the industry’s current environment and the challenges inherent in 
adjusting to the digital surgery landscape. These conversations also helped support 
various aspects of my hypothesis and further clarified many of the frameworks used in 
this research. 
Finally, the literature review examined many of the theories around servitization, 





frameworks to take shape. Much of the literature was able to account specifically for the 
medical device industry; therefore, it helped create a more immediately actionable 
playbook for our mental model mapping. 
1.3 Conclusions and Their Bases (Data and/or Theory): Sections 8–10 
To wrap up the theory with subject matter experts, personal experience, and the 
literature review, the concluding sections of this research highlights many of the changes 
suggested as most applicable to the organizational changes necessary in the medical 
device industry. These sections specifically highlight the concept of systems thinking as a 
foundational change in both business planning and culture for manufacturers to adopt as a 
key area in innovative strategic thinking in the digital landscape. This section begins with 
a look at paradox theory and how the necessary tensions within the concepts of 
servitization help contribute to an improved structure and systems approach. 
The next part of this section will highlight how sales organizations’ culture of 
performance will be dependent on how they train and measure their execution strategies 
as service-focused technology companies. These concepts are then extended to the new 
role of the value chain and how both systems thinking and management innovation 
impact the ways in which value is delivered to the customer. 
1.4 Practical Application: Section 11 
In conclusion, this research highlights several areas utilizing a variety of mental 
models to help shape how device manufacturers can begin to frame their transition. From 
organizational persona to structural design, the final stage of the research will outline 





business. The conclusion will briefly highlight some of the areas where further research 







2.1 Facts About the Topic 
This paper represents an attempt to explore the emerging changes in value-driven 
deliverables for medical device manufacturers as new medical technologies (med tech) 
fundamentally change the way providers and businesses deliver patient care. 
This paper aims to explore the organizational implications for management, 
where market trends drive the adoption of service-based business models within the 
medical device industry and, secondarily, to create a framework for the execution of new 
management models. 
The premise of this analysis is the thesis that large medical device manufacturers 
will be forced to shift their business models from product-driven manufacturing and sales 
to service-oriented business. The strategic focus behind this fundamental shift is based on 
the premise that existing implantable devices are becoming more and more commoditized 
and harder to differentiate through product innovation. Moreover, there is significant 
pricing pressure due to an evolving healthcare environment. Research primarily focused 
on the transition to service-dominant frameworks has been limited and represents a clear 
gap in both theory and practice, particularly in the med tech industry, where a rich 
tradition of product innovation and engineering has built strong cultural norms and 
expectations (Martinez et al., 2017). 
Fundamentally, product- and service-based businesses operate in different 





successfully adjust, from an operational and cultural perspective, so as to compete in the 
changing healthcare environment. The primary questions proposed are as follows: 
1. How do organizations effectively create new cultures and identities? 
2. What are the critical organizational strategies in changing from a product-
focused business to a service-focused business? 
3. How can medical device manufacturers effectively adjust to the market 
prioritization of new software-based technologies?  
The proposed recommendation frameworks are not designed to persuade the 
reader in favor of any specific industry trend or directly lay out the case for a shift to 
digital healthcare. Rather, they aim to create a context where leaders and managers can 
better execute the strategies related to reprioritizing internal business practices. While the 
fundamental theme of this paper focuses on data and expert opinion to support the shift to 
digital healthcare, the primary objective is to better understand how management 
innovation can be effectively implemented in changing business environments. 
The addition of a service-focused component offers a profound adjustment to 
current industry standards and should be highlighted as a critical aspect of this analysis.  
Technical expertise as a new component of value creation becomes a point of emphasis 
as technology evolves beyond the simple relationship between the product and the user 
and requires additional support and expertise.  These paradigm shifts fundamentally alter 
the way device companies will interact with customer and thus, require new modalities of 





This is the first research project that specifically explores the impact of med tech 
on device manufacturers’ business strategy shifting from selling products to selling 
services. The underlying data of the medical device industry shows the growth and 
significant impact of med tech on shaping patient outcomes, including new modalities of 
imaging, robotics, and diagnosis tools based on artificial intelligence (AI). The results of 
this analysis will therefore help the reader understand how medical device manufacturers 
should model alternative positioning strategies (service-based versus product-based) to 
most effectively influence the structural and strategic initiatives within their growing 
technology portfolio. 
The need for technological intervention in healthcare spans a variety of markets, 
driven by the growing demand for data-driven decision-making and assisted surgical 
execution. As much as 70% of all medical errors occur in the diagnostic phase of the 
patient experience (Royce et al., 2019), and according to Johns Hopkins, roughly 250,000 
U.S. citizens die every year due to medical execution mistakes, which is the third leading 
cause of death behind heart disease and cancer. Some data suggests that upward of 
440,000 preventable deaths occur depending on the cause, which ranges from human 
error to systems failure. More specifically, these are categorized as errors of omission, 
commission, communication, context, and diagnosis (James, 2013). The cost of these 
deaths creates an inefficiency of roughly $36 billion, and they occur even in some of the 
most common procedures, leading to a clear area for disruption in the robotic and 
AI/machine learning space built for improved decision-making and surgical consistency 





The growing cost of healthcare continues to be a point of economic and political 
significance around the world. Furthermore, governments are working to reduce 
healthcare costs in hospitals, which are traditionally the most expensive component of 
any healthcare system. Lowering the costs of medical devices while also improving 
patient outcomes have been proven to comprise a significant challenge across all surgical 
specialties has been proven to be a significant challenge across all surgical specialties. In 
spinal surgery specifically, the data shows that upward of 46% of lumbar spinal fusion 
surgeries result in failure, with over one million procedures performed in the United 
States alone (Daniell & Osti, 2017). For complex deformity surgeries, the data shows that 
37% of patients required reoperation due to mechanical failures; this generated expenses 
of over $16 billion in the United States in 2004 alone (Daniell & Osti, 2017; Inoue et al., 
2015). Poor outcomes, high costs, and variability across physician diagnosis and 
treatment are all leading indicators suggesting that the medical device industry is primed 
for disruption through innovation. This growing role of med tech aligns more clearly with 
big data to explore a more specific diagnosis and treatment option, with the ability to then 
potentially automate any surgical intervention. However, healthcare culture poses a 
challenge in adopting these technologies from the perspective of both reimbursement and 
physician training. 
The current landscape of the medical device industry primarily shows a space 
where manufacturers produce products and sell them to hospitals. More specifically, 
device manufacturers develop specific instrumentation or implantable devices that 





or simply a relationship with the company and/or its representatives. Purchasing 
decisions continue to shift in favor of economic buyers with an emphasis on both 
reducing costs and limiting outcome variance. Governments in the United States, Europe, 
and China have implemented tax and regulation policies in an effort to encourage local 
innovation as device pricing continues to experience downward pressure. Medical device 
manufacturers that have historically relied on product innovation through research and 
development (R&D) are beginning to see eroding margins, budget restrictions, and 
reimbursement changes surrounding implantable devices at an accelerated pace (Kapadia 
et al., 2018). 
2.2 Market Observations 
Shifting trends toward new value drivers are forcing medical device 
manufacturers to reimagine their strategic relationships with customers. Devices 
interconnected with adjacent technology are beginning to present significant 
opportunities for manufacturers to reshape their value chains and further contribute to 
outcome-driven deliverables. Variability in both cost and outcome are two of the major 
pain points in healthcare; for instance, analysis shows that the costs of major joint 
replacement (orthopedic) and pacemaker-insertion (cardiovascular) implants can range 
from 5–25% of the episode-of-care-costs, while consumable use in knee-replacement 
surgeries can vary by more than 230% across major U.S. hospitals (Chadha & Llewellyn, 
2019). Regarding the efforts to reduce costs and enhance patient care, growing 
discussions around identifying solutions that standardize diagnostic and surgical 





synergies that meet multiple stakeholders’ needs. While facing the potential for lower 
margins, device manufacturers can take strategic advantage of this gap by claiming 
ownership of the modalities along the healthcare delivery journey. However, this may 
require new competencies (such as data analysis, digital surgery, or analytics). 
Across medical specialties, a growing consensus indicates that innovation in both 
implantable devices and instrumentation can only go so far; the ways to develop a new 
orthopedic screw or interventional needle are limited. On the contrary, these new pieces 
of data-driven technology deliver value to physicians through information sharing or 
automated intervention. Surgical teams are forced to learn new techniques associated 
with robotic intervention or data processing, which differ from traditional medical 
approaches. While an orthopedic screw may not significantly vary between 
manufacturers, a robotic system capable of interpreting individual patient data and 
executing surgical procedures based on this data is a new method through which medical 
device companies can deliver both clinical and economic value. Unlike the current 
management model, these fundamental changes require an organizational approach 
different from delivering implants and instruments that surgical teams have been using 
for years. Companies that fail to recognize and integrate outcome-focused service 
integration into their value chain risk losing market share to competitors that take 
advantage of this shift in focus. 
This research will focus on exploring these healthcare trends along with the 
fundamental premise that selling implantable devices requires a different organizational 





collect and interpret data. Device manufacturers will require new structures, skillsets, and 
training techniques to meet the needs of customers and compete with other manufacturers 
looking for new ways to create value. While some companies are taking steps toward 
these new trends in technological innovation, device leaders should endeavor to balance 
the clinical needs for such innovative systems with fundamental business needs to 
continue selling and innovating their high-margin devices and instrumentation. 
The first companies to successfully adopt robotic or AI systems are now showing 
growth with their implantable devices due to the new synergies with their corresponding 
surgical systems. For instance, in Q3 2019 Medtronic, the second quarter revenue of $692 
million increased by 5.5% as reported or 3.5% on an organic basis. When combined with 
the company’s sales of enabling technology used in spine surgeries – including robotics, 
navigation, imaging, and powered surgical instruments that are recognized in their Brain 
Therapies division – global spine revenue and U.S. spine revenue both grew in the high-
single digits on an organic basis (Medtronic 10-K, 2019). In short, the implant becomes 
less valuable as a growth driver, while value is created for the physician, patient, and 
hospital in the modality of the implant or instrument used in the procedure. 
Other device manufacturers are beginning to recognize the need for patient-
focused outcomes in the physician experience of using new technology to supplement the 
device. Siemens, for instance, has rebranded its healthcare business as “Siemens 
Healthineers,” with sales of over $4 billion in 2017. By entering into strategic 
partnerships with hospitals through innovative service lines, including technology 





the unique value-added aspect of their business (Kapadia et al., 2018). Through a 
partnership agreement with IBM, Siemens, which is traditionally known for its medical 
imaging expertise, will further venture into population health management to analyze and 
improve value-based data for hospital systems, a service business drastically different 
from selling capital imaging equipment. 
The Harvard Business Review estimates that some form of smart technology will 
be used in as much as 90% of hospitals and replace as much as 80% of what doctors 
currently do, from diagnosis to surgical intervention (Longoni & Morewedge, 2019).  
“To successfully collect and report meaningful, measurable outcomes data, 
medical device companies should invest in a digital strategy and technology 
infrastructure that allows them to clearly link data with the device, consistently define 
outcomes and increase transparency across healthcare stakeholders. For this to really 
work, the starting point should be the user experience and corresponding pain points 
rather than the device, so ‘user-back’ instead of ‘device-forward’ – a perspective that may 
be new to traditional players, but familiar to technology entrants.” (KPMG International 
Report, 2018, pp. 1–25) 
2.3 Device Representative/Surgeon Relationships Today 
Device sales representatives (“sales reps”) are generally accepted figures in the 
operating room during surgical procedures in varying capacities across specialties, 
typically preceding the surgeon and surgical staff to ensure all the needed equipment is 
available and ready. The representative’s responsibilities include ensuring that all the 





and verbal guidance throughout the surgery. An intimate knowledge of their implantable 
products, surgical techniques, and hospital systems is necessary to anticipate any mid-
procedure changes or scheduling adjustments to ensure each procedure is carried out 
efficiently. From the standpoint of tangible deliverables, sales representatives deliver 
their value through reliability, preparedness, and expertise in their given product 
(O’Connor et al., 2016). 
While the surgeon is the decision maker in the operating room, device 
representatives work hard to earn trust and maintain strong relationships with their 
customers to ensure continuity and establish a level of influence. Hospitals ultimately 
foot the bill for surgical implants, and surgeons generally have a strong say in which of 
these products will be used – up to 61% of the expense is spent on supplies considered 
“physician preference items” (Montgomery & Schneller, 2007). Furthermore, orthopedic 
surgeons have exhibited a tendency to use only one vendor for most of their implants and 
maintain brand loyalty over an extended period of time (Burns et al., 2009). They also 
tend to ally more closely with their device representative than the other hospital staff 
(Korenstein, 2010). For instance, one orthopedic surgeon claimed, “I use [the reps] 
because they give me good service…I think that the products are all fairly similar” 
(O’Conner et al., 2016). 
The decisions influenced by both representatives and the industry also have 
implications within the Food and Drug Administration’s (FDA) 510(k) approvals, which 
indicate that implantable devices ruled as “substantially equivalent” to current market 





manufacturers to avoid the significant delays and costs associated with pre-clinical 
testing and validation. As the discussion around computer-automated decision-making 
and surgical robotics becomes more prominent, these FDA-related equivalency factors 
become reliant on the industry to ensure the correct use of these new technologies. 
Over time, the medical device industry has become increasingly cost competitive, 
although brand recognition and the surgeon–representative relationship remain two of the 
key drivers in the success of sales. Impactful innovation has become a challenge 
considering the commoditized nature of many implantable devices, allowing for lower-
cost alternatives to gain a share through lower prices and innovative business models. 
The ongoing shift toward cost-conscious hospitals and economic decision-making are 
restraining the manufacturers’ ability to bring newer or more premium products into 
hospitals. Considering the commoditized nature of the bulk of these implantable devices, 
hospitals are willing to settle on fewer venders and cost-conscious purchasing decisions 
for a combination of quality, service, and innovation. The device space will continue to 
see competitors emerge with cost-competitive pricing, forcing hospitals to view most 
devices in more of a commoditized fashion, with numerous products and few 
differentiating features. 
2.4 Hypothesis: The Shift from Products to Services 
The research assumptions are based on both my personal experience as well as 
trending economic data on growth in the med tech sector. In conjunction with shifts in 
purchasing decisions and a clear clinical need to further standardize medicine in a more 





manufacturers will inherently need to reprioritize multiple segments of their business to 
better meet both clinical and financial needs. The most important assumption is the belief 
that the modality in which implants are delivered will ultimately become more significant 
than the implants themselves; recommendations will be made based on this. The new 
service focus established by med tech companies through complex capital equipment will 
ultimately become the new value driver for daily interactions with physicians and 
administrations. 
Additional assumptions are seen through the lens of the specific need for 
management innovation within the industry from both structural and cultural standpoints. 
While there have been tremendous medical advancements, the industry culture was 
formed at a time when iterative improvements to both instruments and devices were the 
markers of success. The industry veterans or companies built on mechanical engineering 
may face challenges in accepting the new opportunities presented with the shift to service 
and digitally driven technological demands. The assumption that the industry’s role in 
healthcare will have to be revamped to fit these suggested service models may not be 
prioritized by many of the current market players. 
This research topic is specific to the shift from product sales to digital servicing, 
but I also hope to make this reflection a clear roadmap of how medical device leaders can 
contextualize the complexities around reprioritizing strategic approaches to any new 
value-added activity. In many instances, particularly due to an established culture and the 
resulting complacency, the concept of “device as a service” may not be seen as a strategy 





driven by those companies that are able to deliver value in new ways that go beyond 
merely manufacturing implants. 
Finally, the assumption that med tech will change the industry as a whole is the 
reason for this paper. I believe the future role of the physician will fit in somewhere 
between data collection and the interpretation of the patient’s diagnosis, where surgical 
intervention will be systemized and scaled across robotics and imaging to deliver 
consistent and predictable results. Thus, the variability in diagnoses and surgical skillsets 
will be significantly minimized. 
“The industry itself thinks very linearly. These traditional models for engaging 
with customers and marketing products creates hurdles and mental blocks. As digital 
surgery becomes more impactful, we as both individuals as well as organizations need to 
develop more into sources of value and information to become true trusted advisors. 
Healthcare is traditionally a very conservative industry and you can see very clearly how 
manufacturers reflect that same tone. Current organizational models simply haven’t 







3. Personal Background and Context  
I’ve developed the phrase “med device as a service” to best describe my personal 
experience as well as beliefs regarding the ongoing changes in the medical device 
industry. I used this experience as a catalyst on my journey through the University of 
Pennsylvania, with two clear goals; first, to build on the educational framework of 
organizational psychology that I have been exposed to in my professional life, and 
second, to develop myself into both a divergent thinker and leader in the field of med 
tech. The idea that the medical device industry will undergo a significant overhaul due to 
the value created by new robotic and AI systems is an extremely divergent one because 
of the industry’s current culture and approach to systems thinking. While my experience 
has helped cement my conviction about these ideas, the industry as a whole is slow to 
adapt. 
My journey began on the clinical sales team of an early-stage robotics company 
whose specialty was spine surgery. The company and its culture had been built and 
developed by leaders who had prior experience working with the world’s most successful 
surgical robotics company, Intuitive Surgical, whose da Vinci robot is used for a 
multitude of general surgery procedures. The company generates revenue through three 
primary buckets: selling robotic systems to hospitals, service contracts for maintenance, 
and a disposable cost associated with every procedure conducted. With more of a service-
focused sales model as compared to most device companies, Intuitive’s sales 
representatives spend time in every procedure, not selling products but aiding the 





being used efficiently to the surgeon’s approval, it will be used more; this may promote 
more sales. Other operating room sales representatives add value by selling and 
delivering either instruments or implants for the physicians so that the surgical staff has 
the necessary tools for the operation. While the timeline of these devices is on the 
shoulder of the representative, the operation, decision-making, and ultimate outcome are 
still up to the physicians and their staff. 
My personal experiences in the operating room with spinal robotic systems have 
been with both orthopedic and neurosurgical spine physicians. The spine is an extremely 
competitive area of orthopedics and neurosurgery due to the limited variation of spine 
implants and the high number of competitors in the field. For the most part, 
representatives rely on the strength of their relationships with physicians to earn their 
trust and continue the business arrangement; it is common for physicians to remain loyal 
to one or two companies. Because of this dynamic, it becomes challenging to earn a 
surgeon’s business or convince them to switch from one company to another, barring 
significant changes to the innovative or competitive landscape. Despite this, I had the 
opportunity to gain access to many surgeons because of the new robot, though not 
without the setbacks inherent in early technological adoption. My job involved planning 
the spinal procedure with the surgeon, defining the location and sizing of the implants, 
and directing the robot while the surgeon performed the operation. For this, immense 
trust and communication were absolutely necessary, to the point where the robot was 





I was granted access to some of the most prestigious facilities and physicians in 
the world, which was unique for the industry. It sometimes felt as though the added value 
and reliability our representatives were able to deliver in these surgeries went far beyond 
those provided by traditional implant representatives. Simply put, we were building a 
business around our service, similar to what Intuitive Surgical had done in general 
surgery. While the implant representatives struggled over the pricing and differentiation 
of their commoditized implants, robotic surgeries were making procedures faster, more 
predictable, and prone to less revisions. The value-add of a robotic representative was 
simply a newly created space in the operating room. As varying robotic systems, data 
collection devices, and AI computers become more integrated into the standard of care, it 
is clear to me that the commoditization of normal medical devices will be driven by 
competing device companies’ capacity to add value through outcome-driven technology 
in combination with service-based representation. 
Several years later, I have worked for both the largest medical device company in 
the world and the largest healthcare company in the world; in both, I worked in 
orthopedic and neurosurgical imaging and robotics. I have built relationships with med 
tech leaders, ranging from physicians to creators of other technology-driven systems, all 
over the world; thus, I have gained a highly diversified perspective. While variability 
certainly exists among different specialties and the technology used, I continue to 
maintain a strong conviction in my thesis that the future of healthcare will be driven by 
med tech services as a means to promote implant growth and add value to surgical 





generally, the leadership culture of medical device companies will need to significantly 
alter its current business framework as the focus and expertise remain on developing and 
selling products. I often pose the following statement: if we are developing devices that 
do not contribute to improving an outcome, we need to innovate how we do business. 
Robotics, AI, and data-driven solutions are all worth pursuing. 
3.1 Observation of the Experience 
Having stepped out of my role in the operating room, part of my experiential 
analysis is based on objective reflections concerning where the business had started as 
compared to today’s clinical standards. Part of this journey led me to experience multiple 
innovative iterations, new product launches, a strategic acquisition, and the 
implementation of the technology in a large organization with a strategic intent. 
Throughout this experience, the clinical expectations of hospital stakeholders had 
significantly shifted from the early adopter phase and into an accelerated commercial user 
base, which had high expectations and little room for error. Both the continued adoption 
and clinical success of our highly technical robotic system were doubtlessly driven by the 
expertise the representatives displayed in every procedure and the level of trust they had 
built with their physician customers. Considering the aggressive scaling efforts, the 
technology itself would likely have experienced failure without the level of service and 
support that accompanied each clinical procedure. 
Depending on the complexity of the device or equipment used in a procedure, 
hospitals and manufacturers can evaluate both sides of the equation on a case-by-case 





leaders may look at such highly technical equipment and suggest that more user-friendly 
solutions should be made available in an effort to lessen the learning curve for the 
physicians and staff, facilitating a more autonomous experience. On the other hand, 
because of the impactful clinical outcomes driven by the use of robotic technology, our 
company was able to develop a reliance on the representatives for every procedure, 
creating a significant competitive advantage that others could not replicate. The robotic 
representatives were able to gain access to surgeons and build trust with them in a much 
shorter period of time than usual due to the representatives’ high level of competence and 
expertise. 
Another salient observation formed from my experience with large, multinational 
medical device companies is concerned with the internal culture and emphasis on 
building, scaling, and further developing such digital technologies from the standpoint of 
customer interaction. Management tends to emphasize the technology’s clinical efficacy 
rather than promote reliance on the representatives to ensure successful outcomes. 
Furthermore, due to the described disconnect, I have seen a significant variation in 
physician and representative training, which leads to the conclusion that we may be 
experiencing a fundamental misunderstanding of what drives the success (or failure) of 
these digital programs. Often, I have observed just the opposite – poor clinical outcomes 
due to a poor or inexperienced representative. Regardless, the outcome of the procedure 
is heavily driven by the competence of the representative, particularly for new adopters of 





“Successful companies have both strong capital salespeople and are backed with a 
strong clinical team. You can’t be fully product-focused or fully service-focused, there 
has to be a blend. The best med tech startups have divergent growth strategies – some 
product and some service – a sliding scale for every product depending on the need. 
Financially you have to be able to scale the service and product, the real focus needs to be 
very front-end heavy on people and allowing those individuals to be challenged enough 
to fully engage.” – Vice President, Surgical Systems (Interview, October 2020) 
The larger players in the field are clearly recognizing the need for digital solutions 
in their business portfolios, but I question whether these companies have a clear idea of 
what it takes to become successful in digit healthcare. In my experience, company culture 
and inefficient value chains comprise the dominant train of thought, without a true 
understanding of how these digital systems will fit into the healthcare ecosystem. Rather 
than creating organizational strengths around real-time service requirements where true 
value is created, the digital solutions are simply being added as a new tool within the 
product portfolio for salespeople and marketers to push as the “next best thing.” 
3.2 Who Are the Experts? 
Human beings generally have favorable biases toward their own judgements and 
abilities along with a strong propensity for recognizing a lack of expertise (Burson et al., 
2005). Simply put, sometimes, “we don’t know what we don’t know.” We are often 
guilty of assuming experts in one field are knowledgeable in another, confusing general 
intelligence with expertise in a specific field, or even confusing factual knowledge with 





experts can successfully recognize other experts in the same field. Therefore, we have 
mechanisms such as peer-reviewed literature to formulate a consensus among these 
groups. Because of the shift into a service-oriented digital environment, which is not 
traditional to medical device manufacturers, we can surmise that currently, device leaders 
“don’t know what they don’t know” due to lack of experience and expertise in the 
growing med tech space. 
To date, we have seen several companies and relative company acquisitions that 
have successfully built and incorporated digital capital equipment into their business 
portfolios. Whether looking at these models as opportunities to learn or simply framing 
their current experience to develop a more open mindset of acknowledging the unknown, 
device leaders should take the time to recognize these blind spots to seek growth and 
expertise. 
3.3 Industry Thesis 
The thesis of this research is built on the premise that in order to remain 
competitive, device manufacturers will need to fundamentally shift their current focus 
from solely selling implants and instruments toward delivering value-added service 
through robotics, imaging, telemedicine, or other forms of interconnected technology as a 
means to deliver implants in a more customized way. The medical device industry is in 
need of more patient-focused solutions, where new technology poses an opportunity for 
creating more customized and predictable outcomes. While selling medical devices will 
always remain the ultimate goal of manufacturers, the emerging demand for new systems 





management innovation. As demands change across healthcare, the culture and focus of 
device manufacturers should change as well; these have traditionally operated primarily 
in a capacity where instruments and hardware were the basis of growth and success. 
To fully succeed in this new environment, medical device manufacturers will 
need to expand their role; rather than limit their presence to the operating room at the 
point of purchase, they should be present throughout the patient journey, from diagnosis 
to recovery. Direct customer-facing interactions will need to evolve in a manner that 
provides real-time service at every stage of the user’s experience. Real-time response and 
troubleshooting require interaction with the technology for both pre-clinical and ongoing 
training so that the stakeholders can ensure the safe and efficient use of the technology. 
The Harvard Business Review conducted a survey of 270 corporate leaders in 
strategy, innovation, and R&D roles in large companies in an effort to gauge the most 
common obstacles to innovation. To highlight the additional burdens faced by medical 
device leaders outside of shifting market needs, the results of this survey also layered in 
some of the less overt challenges that larger companies faced internally. The top three 
challenges were political battles and lack of alignment, cultural issues, and the inability to 
act on signals crucial to the future of the business (Kirsner, 2018). As we combine these 
results with the lens of the medical device space and healthcare, the pressure on leaders to 
adjust business trajectories and build new competencies becomes extremely challenging 





3.4 Creating New Layers of Value – Med Tech Representatives 
A new layer of value is slowly being created in the med tech space, where the 
most important company representative in the operating room is able to provide real-time 
consultation, digital expertise, and consistent workflow management of all digital 
technology to aid the physician and ensure smooth and efficient outcomes. Nowadays, 
medical device companies’ representation in operating rooms is very specific to the 
nature of each individual company’s business needs. Most device manufacturers’ 
representatives are salespeople with the responsibility of providing the required 
instrumentation and reliable product expertise throughout the procedure when needed. 
Commoditized pricing pressures place a high reliance on the relationship between the 
physician and the representative to maintain business. 
Emerging software and robotic companies in the medical device space provide 
slightly different clinical representation, directly reflected in their respective business 
goals. For instance, Intuitive Surgical has the very specific need to ensure good user 
experience and system utilization. With no tie to an implantable device, Intuitive’s 
representatives act as real-time experts to ensure the system is being used appropriately 
and effectively, which, in turn, encourages continued use. A slightly different example 
involves how some med tech players – such as Brainlab, in Munich, Germany – consider 
themselves to be software-based companies focused on imaging and data. Their capital 
equipment is generally comprised of imaging and navigation systems in addition to a 
highly diversified network of cloud-based computing options for hospitals. With no 





requires clinical representation for troubleshooting scenarios and little emphasis on 
additional sales needs. 
The current role of sales representatives remains consistent across specialties, 
with some variance depending on the procedure, competition within the specialty, and 
level of complexity involved in the setup and use of the instruments and devices. 
Regardless of whether they are a direct device salesperson or software-based clinical 
specialist, the best representatives are known for being highly reliable and knowledgeable 
and sometimes play a role in consulting on their respective technologies beyond the 
scope of their service. 
The proposed thesis posits that implant companies will need to functionally and 
culturally shift to the service-oriented business approach to ensure the continued growth 
of their implantable business. The oft-touted marketing mantra, “service builds value,” 
will hold true as device manufacturers adopt new forms of digital technology to further 
enhance and differentiate their outcome-focused solutions. The reliance on digital 
expertise helps build and develop relationships between the company and hospital 
stakeholders in an unprecedented manner. The companies with both service-oriented and 
patient-focused sales force and infrastructure will have an opportunity to differentiate and 
create unique value beyond the core business of implant sales. As Theodore Levitt said, 
“Customers attach value to a product in proportion to its perceived ability to help solve 






3.5 The Business Moat Opportunity 
By providing quality service and integrated systems of hardware and software and 
by bundling multiple capital expenditures into connected solutions, medical device 
companies have the opportunity to create an economic “moat” around their business. 
Currently, manufacturers fight for competitive advantage in a variety of ways but 
ultimately fall short of sustained long-term success. The differentiator of a moat is the 
sustainability of the business due to high switching costs, product stickiness, and 
intangible assets such as relationships or system familiarity. Strong economic moats 
create environments where competitors have a difficult time persuading customers to 
switch to a rival offering. Because of the introduction of big data and machine learning in 
healthcare, the access and use of such information provide just one example of a starting 
point for companies with regard to engaging with customers on a more integrated level. 
3.5.1 High Switching Costs 
The switching costs associated with digital health are examined from both 
economic and clinical standpoints; the main drivers are price, risk, and inconvenience. 
Major capital purchases or network-wide software integration are not frequent capital 
expenditures made annually, as budgets typically have built-in room for upgrades or 
additions over the depreciated lifespan of the system. Once systems are sold and 
integrated, the opportunity for a competing system to replace the newly acquired 
technology becomes narrow. Clinically, as hospital staff and physicians are trained and 
go through the learning curve of adopting new systems and, in some cases, completely 





capital equipment become ingrained in their daily operations. While the medical device 
industry is known for having some barriers in this realm with regard to certain 
implantable devices or instruments, adopting fully integrated robotic systems or AI 
requires completely new expertise and training. 
3.5.2 Stickiness and the Network Effect 
Businesses create network effects when users gain more value as the users, data, 
and streams of technology in the ecosystem increase in number. As companies build 
more robust pipelines of digital technology, the interconnected nature of each piece of 
hardware and software builds a significant barrier for competing devices or systems. For 
example, hospital system networks tied to data management may feed specific patient 
information to a surgeon who, in turn, is able to determine the most appropriate treatment 
option. The provided information generates custom patient implants to be used with 
instrumentation that may only be integrated into a specific robotic system to aid in the 
procedure. This scenario can continue in any direction depending on the interconnectivity 
of the company’s digital systems, but the main idea is that a robust value chain helps 
drive efficiency and cost control in the hospital setting. 
3.5.3 Intangible Assets 
The most important aspect of the digital shift will be the relationships with the 
industry, both through daily interactions and the brand. The emergence of new modes of 
treatment and interpretation create a strong gap in healthcare as physicians and hospital 
systems alike strive to adopt new ways of providing care. Whether the sales 





collection centers receiving orders of custom sterile implants, the reliance and 
relationships on the individual level that support and service new technologies help 
justify participation and fill the gap as stakeholders go through a generational learning 
curve. The brands associated with these services and new technologies have the 
opportunity to create or reinvent an image based on the level of service provided at the 
point of care and throughout the treatment life cycle. Additionally, med tech presents a 
strong opportunity for businesses to build a patent portfolio around their respective 
technologies, which can serve as a strong economic moat. 
As robots are sold to hospitals or new machine-learning software is built into the 
facility, the company selling the package has earned the right to interact with the facility 
or “be in the room.” Meanwhile, the opportunity for a competitive company to integrate 
their own systems sometimes becomes blocked or “priced out” of future business. The 
stronger integration a company has across its technology portfolio, the greater the 
opportunity to utilize cross-functional synergies in an effort to drive high-margin 
implants despite the potential for lower costs. In an environment where hospital systems 
continue to look for ways to limit vendors, the device companies that can provide the 
most value-add through technology are beginning to earn more business opportunities 






4. Servitization in Medical Devices 
“Are you buying the product, the people, or the problem? If you don’t want the 
people don’t expect to solve the problem.” – Vice President, Surgical Synergies 
(Interview, November 2020) 
4.1 As a Competitive Advantage 
Servitization can be defined as the complex process by which a company shifts or 
expands from selling products or basic services to delivering customized solutions 
(Kohtamäki et al., 2020). For any organization, initiating the shift to servitization requires 
a reshaping of the value chain; for manufacturers, this is traditionally rooted in three main 
paradigms: (a) vertical integrations of production and delivery to standardize inputs and 
outputs, (b) superior product development through R&D efforts, and (c) generation of a 
sustainable market position to strengthen the economies of scale (Bustinza et al., 2015). 
As the research indicates, medical device manufacturers have an opportunity to 
increase differentiation, customer satisfaction, and build “business moats” in an effort to 
achieve superior competitive advantages and performance through service-driven 
activities and organizational focus. The proposed efforts to shift to service require 
manufacturers to create and capture value throughout the life cycle of both the connected 
products and across the interconnected organizational system as a whole. 
Porter and Ketels (2003) point out the opportunity to generate a sustainable 
competitive advantage by allowing firms to avoid competing on product cost and 
innovation and by facilitating greater differentiation and increased customer satisfaction. 





increased emphasis on the service opportunity as physicians and hospital systems are 
already accustomed to daily interactions with the industry and its representatives, who are 
often relied on as real-time aids during procedures. Furthermore, the growing need for 
manufacturers to focus on patient- and outcome-driven solutions presents an opportunity 
for insurance payers to play a greater role in which technologies are best suited to drive 
the desired results. A variety of studies show results indicating consistent, though 
nonlinear, positive relationships between service implementation and company 
performance and long-term profitability, specifically through differentiation and 
customer satisfaction as outlined earlier (Baines et al., 2009). 
In many instances, smaller companies’ ability to remain agile while larger 
companies move slowly is incredibly impactful in the medical device field. Discussing 
the topic of differentiation and customer satisfaction with a marketer from a larger device 
manufacturer, an additional layer of insight was obtained, which exhibits growing 
significance (Figure 2): “Time to market is the new differentiation. Customer satisfaction 
will always remain and important aspect of our business. We’re learning that in order to 
be successful, we need to be faster to market and make strategic partnerships in an effort 
to increase our speed. Robotics, for example, will be largely similar pieces of equipment 
in the future. How do we get to market first and begin collecting the data that will help 








To further outline the economic advantages of service as a competitive advantage, 
the analysis conducted by Bustinza et al. (2015, pp. 53–59) specifically examined 
medical device manufacturers to better understand the impact of offering services in 
addition to traditional products, intending to “better understand the extent to which 
companies are able to create value by evolving their service strategies into an outcome-
based model.”  
The results suggest a growing belief in advanced service offerings being the 
highest revenue driver across the service continuum in addition to a projected increase in 
revenue across all service offerings within the value chain; there is an understanding that 
the newly developed capabilities will be the basis for sustained competitive advantage. 
Interestingly, specific to medical device competitive advantages, there is little evidence to 
suggest differentiation specifically through service offerings; rather, competitive 
advantage is likely to be achieved through customer satisfaction, which, in turn, strongly 
aligns with the need for improved efficiency and patient outcomes (Baines et al., 2009). 





Annarelli et al. (2016) introduced the concept of product service systems (PSS) as 
a model for marketing organizations around combined product and services, often as a 
result of a shift into servitization through added service to sell products or complete a 
change in the payment structure of the product. Relative to the content of this research, 
the most prominent PSS-related shift was outlined by Tukker (2004), who pointed to a 
results-oriented business servitization model that could potentially exhibit growing 
promise in healthcare. Schmidt (2016) built on this research to show the increasing 
importance of PSS in accepting technological innovations but without potential pitfalls 
along the way. The continued evidence of this in both theory and practice, as outlined by 
the brief summary of available literature, emphasizes the positive influence the service 
aspect of medical devices can have on competitive advantage in an increasingly 
commoditized healthcare industry. 
4.2 Customer Perceived Value 
The works of Baines et al. (2009) and Raja et al. (2013) conclude that prior 
literature indicates a reliance on service integration as a “conscious and explicit” strategy 
for data-driven competitive advantage. Enforcing a service offering to enhance customer 
value creates a new customer experience, which inherently becomes reliant on the 
interaction between the customer and the business on a level beyond the use of any single 
product. The service delivery system gives the company an opportunity to build stronger 
and more interactive experiences with customers and also facilitates an atmosphere where 
the experience can be more closely evaluated, thus creating stronger competencies for the 





have the chance to accelerate these learnings and create custom solutions, where 
customer satisfaction and patient outcome can both rapidly improve in shorter periods of 
time. 
“The conversations that my team is having with surgeons is very different than 
the one’s our implant team has. It’s much less of a relationship and more of a technical 
deep-dive on exactly what the surgeon wants to achieve. The surgeons respond very well 
to the coaching and direction we give them, and, in a way, we become a member of their 
team. They see value in the service we provide because it ultimately makes their lives 
much easier.” – National Robotics Manager (Interview, September 2020) 
As value improves with increased interaction and customized solutions, 
manufacturers also run risks of bad user experiences or the emotional implications that 
accompany communication and the reliability of poor interactions with the service aspect 
of the business. Despite improvements in technology, failure is an unavoidable aspect of 
any piece of medical equipment throughout its life cycle; it can be caused by user error, 
which only places further emphasis on an organization’s ability to engage with the 
customer in an appropriate fashion. Zeelenberg and Pieters (2004) emphasized the 
negative emotions experienced by customers, which subsequently drive behaviors that 
may impact the service company, such as negative word of mouth or reluctance to 
maintain a business relationship. 
“In my experience with robotics, the technology is only as good as the coach or 
person running the system with the surgeon. In the future these people may go away and 





experience of the rep is the key to any program being successful and our hospitals 
adopting our systems. The biggest challenge is finding the experts who can facilitate 
these procedures and the time it takes to build experience. It’s been a challenge to scale.” 
– Robotics Clinical Manager (Interview, September 2020) 
The influence of emotions on consumer behavior has been shown to stem directly 
from the specific emotional lens of the customer as opposed to dissatisfaction with the 
experience itself (Walker, 2018). As we investigate the growing need for a service focus 
in med tech, note the higher price of poor performance due to the nature of the work. 
While governing bodies such as the Food and Drug Administration (FDA) enforce 
adherence to strict medical standards, the possibility of poor user experience remains 
strong and costly. Vázquez-Casielles et al. (2007) showed that when consumers 
experience service failure, they tend to immediately look for causation, and attributing a 
cause can provide a perspective for assessing customer reactions to a failed service. 
When dealing with poor training or user errors, experience has shown that healthcare 
providers in highly stressful situations can be quick to blame the service or technology, 
particularly when the payers and reputation are on the line. Here, the challenge lies in 
diagnosing the problem and responding to the service failure; if correctly positioned in 
the value chain, these can be mitigated long before the problem occurs. 
“The training team sets the expectations for the surgeons, but the reps have to 
continue to reinforce those explications throughout the learning curve. These 





they aren’t having a good experience with our capital systems, why would they use our 
implants?” – Digital Technologies Regional Manager (Interview, October 2020) 
4.3 Market Positioning 
“Digital healthcare is a much different mindset for our organization.” – Vice 
President, Digital Strategy (Interview, November 2020) 
Compared to other industries, healthcare occupies a unique position, where much 
of the value chain is delivered downstream in customer-facing scenarios when aspects of 
the organization, such as a service branch, begin to amplify those downstream 
experiences. From the research referenced earlier, it can be deduced that different 
servitization strategies lead to different outcomes depending on an organization’s position 
in the value chain, where the concept of differentiation is not directly linked to 
performance in downstream industries such as medical devices; rather, customer 
satisfaction becomes the leading indicator of a successful strategy (Bains et al., 2015). 
Because the medical device industry has such a variety of specialties and niche products, 
the concept of shifting to a service focus can allow manufacturers to continue to innovate 
and develop at a comfortable pace while allowing the commercial branches of the 
organization to innovate based on how the customers perceive them. Once systems 
thinking is integrated into the strategy, new product development can become a feedback 
loop directly tied into the customer experience with the service organization, where firms 






Downstream customer satisfaction is identified as the key driver for the successful 
prioritization of service models. The biggest organizational challenge in the digital shift 
lies in the current downstream sales force structures related to in-house sales 
representation versus outside distributor-based representation. Choosing between in-
house or external sales partnerships is a key strategic decision for device manufactures 
for a variety of reasons, particularly in an industry where sales force relationships and an 
open R&D feedback loop are critical. Often, a device manufacturer or smaller firm can 
surpass the complexity of developing a commercial organization by partnering with 
external distributors that have existing links to customers; however, this results in the 
manufacturer sacrificing the opportunity to directly develop new relationships. The lack 
of direct contact with the customers can potentially impact upstream product 
development. 
The analysis of a firm’s changing downstream market opportunity concludes that 
an external relationship with a partnering sales organization remains the most valuable 
and relevant when the two firms continue working together in the same product market, 
such as orthopedic implants. This subsequently diminishes when the manufacturer enters 
a new downstream opportunity. The analysis of 545 U.S. medical device manufacturers 
considers “new markets” to also include innovations such as digital health, where firms 
have traditionally had more success with sales in-house. However, the research also 
creates room for opportunities as innovation grows and develops toward the 





Over time, separate and distinct firms can build trust, develop shared norms that 
dictate acceptable behavior and facilitate coordination, and create routines that enable 
efficient actions. These features, collectively labeled “relational capital,” facilitate the 
development and transfer of relationship-specific knowledge across firm boundaries 
(Poppo & Zenger, 2002) and therefore underpin effective relational governance 
(Elfenbein & Zenger, 2013; Zaheer & Venkatraman, 1995). Based on past experiences 
and expectations of continued future exchange, partnering firms make investments in 
developing knowledge and other assets specific to their relationship. 
The focus on market positioning from a downstream perspective certainly makes 
a tremendous impact in the medical device field but not without the need to focus on 
building companies more closely related to those that have had success in related 
software-based industries, such as the enterprise software (SAAS). Med tech 
organizations should first look internally into their hiring processes and cultural practices 
in order to correctly position efforts to shift priorities to new potential revenue streams 
and prepare for future market adjustments. The interviewed subject matter experts are 
aligned in terms of general cultural and business practices, which may need to evolve as 
the market becomes more digitally focused. 
“Big companies struggle the most with execution when it comes to digital 
innovations. It’s hard for us to innovate because we don’t know what we don’t know. 
Smaller digital med tech companies are always future-focused and aspirational, rarely 
living in the moment. It allows them to move quickly in a generally slower, more 





innovation because they have brand recognition and won’t be able to outpace the market. 
The cultural becomes a challenge when you don’t have a true visionary or digital subject 
matter expert in a leadership position driving the ship.” – Global Commercial 
Development Director, Robotics (Interview, August 2020) 
4.4 Training and Knowledge Development 
“Small companies need access; large companies need the skillset. That’s just 
where we are. Our training, the mental state of our field sales force, and the effort they 
are required to put into learning the complexities of new technology – Is this really 
doable considering who we are? – Commercial Leader, Orthopedic Manufacturer 
(Interview, September 2020) 
As traditional medical device companies start focusing on service-driven 
initiatives, new competencies and norms inherently become a critical priority for 
successfully implementing the necessary organizational changes. While countless 
research projects demonstrate the importance of specialized knowledge for any successful 
business or organization, the performances of product and service organizations are 
impacted very differently depending on turbulent market conditions. Regarding the 
theoretical groundwork for a “knowledge-based” view of competitive advantage, 
Schroeder et al. (2002) suggested that knowledge is the key strategic resource, which 
leads to superior performance, for any organization. The dynamic tensions between 
knowledge development and the culture of competitiveness as the two key aspects of the 





for delivering high levels of performance outcome. As a measurement scale, performance 
is specifically the evaluation of profit, cost, and growth. 
For traditional manufacturing businesses, knowledge management is concerned 
with making the right knowledge available at the right time (Holsapple et al., 2015). 
Using knowledge as a dynamic and evolving capability involves processes such as 
knowledge acquisition, sharing, application, and creation (Lichtenthaler & Lichtenthaler, 
2009), which theoretically extends across all businesses and organizations. Looking 
specifically at the differences between service and product companies, Hult’s framework 
further differentiates between the concepts of knowledge development and competitive 
cultures and where performance is most impacted. 
The research evaluation looks at how these dynamics affect firms during market 
turbulence, defined here as market disruption through digital innovation. While 
knowledge development is shown to be linked to superior performance, the reasons are 
indicated to be due to cumulative experiences and manufacturing performance, where the 
ability to value, assimilate, and apply knowledge reflects operational know-how and 
improved results (Pisnao, 1994; Rosenzweig & Roth, 2004). The insights, experience, 
and skills gathered by a firm’s routines and beliefs help contribute to bringing new ideas 
and opportunities for improving firm performance; however, these insights are specific to 
product manufactures and fail to account for the assumed shift to service required by 
medical device manufacturers. 
When new markets emerge and demand a shift to service-based models, 





new competencies with undefined expectations. Past knowledge may prove to be less 
useful in newer environments where organizational memory may actually lead to inferior 
performance (Macau et al., 2016). Because service is an intangible good, knowledge 
becomes the main input as opposed to manufacturing, where tangible goods and the 
required materials are the key drivers. Therefore, in the service business, where customer 
involvement and customization are critical factors of success, Kiano et al. (2010) 
suggested that human capital is a more important factor as compared to manufactures. 
“The biggest lesson learned about commercializing new medical technologies is 
simple: Sell first and focus on the relationship second. Innovative technology has proven 
to supersede the relationship, the widgets no longer matter. We’ve had surgeons willing 
to sever long-standing relationships in favor of the new technology, so credibility is 
quickly more important than relationships which traditionally drive our industry forward. 
As a company we’re trying to get away from the knife-fight and change the way our 
customers make decisions, but it takes time to change the current trajectory our customers 
have been on for their whole careers.” – Technology Leader (Interview, September 2020) 
Service shifts will require new norms and beliefs that may challenge the current 
thinking of many manufacturers, who rely heavily on knowledge development to improve 
business processes. The analysis discussed the need for open competitiveness in 
conjunction with continued knowledge development to avoid being hindered by prior 
belief systems. Because service businesses are more vulnerable to heterogeneity, variable 
and non-standard methods may need to become part of the initial learnings as 





expectations, norms, and standards will need time to develop and fit into the existing 
value chains, from both commercial and product development standpoints, despite the 
high expectations from customers and regulatory bodies. 
“It’s all about breaking the precedent; we’ve been extremely disruptive from both 
professional and commercial educational standpoints and it’s allowed us to gain a 
significant competitive advantage because we focused our efforts on the people and the 
business as opposed to just the product. We’ve played a significant role in the 
commercial sales organization and understand that the technology will do its job. It 
becomes the clinical or salesperson’s competence that becomes the limiting factor.” – 
Training Director, Digital (Interview, November 2020) 
4.5 Management Implications 
“Losing business will not bend on our long-term vision.” – Commercial Leader, 
Orthopedic Manufacturer (Interview, September 2020) 
The referenced literature has established that knowledge development will vary 
for medical device manufacturers that are shifting their focus toward the service business, 
where knowledge and information are the main intangible input and output as opposed to 
traditional product manufacturers, who rely on tangible materials and design. These 
differences will drive a change in how knowledge is managed and incorporated into the 
organizational processes to achieve competitive advantages and successful technological 
implementation. Med tech businesses will have to ask several questions outlined by 





management between product and service businesses and how to implement best 
practices. 
The distinctive differences between products and services are largely dependent 
on the human capital aspect of the organization that is the primary point of emphasis. The 
process of knowledge sharing needs to become an efficient driver for organizational, 
individual, and customer behaviors to help drive strategic decisions and build 
competitiveness within the newly developed aspects of med tech. Knowledge 
management focuses on an organization’s ability to consciously develop activities and 
practices around continued knowledge processes in the development phase of any new 
project. Hansen et al. (1999) suggested that a knowledge management process must have 
a direct link to organizational strategy, whereas a service-based business mostly relies on 
human capital to excel. Furthermore, around the suggested links to strategy, they built a 
framework for the quadrants of focus: organizational design, organizational culture, 
human resource practices, and management of information and communication 
technology. 
A majority of the organizational literature focuses on culture as the key ingredient 
for knowledge management, with direct links to the creation and sharing of information 
(Davenport & Prusak, 1998). History, expectations, and unwritten rules are some of the 
most common themes when defining a culture, where many of these norms significantly 
influence communication behaviors. Many of the largest medical device companies at 
present can be considered very different from the newer and more innovative players who 





significantly vary among the new entrants. When some of these companies are acquired 
as strategic initiatives by larger manufacturers, their cultures clash in a variety of ways. 
Beyond the culture, med tech manufacturers also have to look at the other 
strategic initiatives around servitization, including design, human resources, and 
information technology, which may vary from the current industry standards. In a service 
environment where human capital is the main strategic advantage, programs to support 
knowledge growth and sharing garner a larger focus for each of the three suggested areas 
of prioritization. Human resourcing and new means of information technology may 
present opportunities for creating practices around initiatives to help build cross-
functional support for servitization as well as for creating programs to build and retain 
talent, where a reasonable hypothesis would suggest a clear link to success in service 
businesses. Particularly regarding organizational design, the same process would be 
needed to ensure a connection to the strategy around service. New structures may present 
an opportunity to be taken advantage of, which would potentially lend a different 
perspective to traditional cross-functional structures. 
“The key for our brand has to be the unification of our vision. We’re already 
seeing technology getting to the point where physicians can no longer afford to remain in 
their current state of practice. We still have a disconnect between our sales force and our 
strategic vision because the long-term goal for the technology doesn’t necessary move at 
the same speed as their quarter over quarter initiatives. The reason we can stomach 
slower growth and development is because these initiatives are being driven at the 





success. Mid-level management doesn’t have to continually sell the idea which gives us 
all the ability to focus on development and competence.” – Commercial Leader, 






5. Geometric Thinking 
“Organizations need solutions, not suggestions. Too many suggestions can lead to 
paralysis by analysis.” – Med Tech Executive (Interview, September 2020) 
Reverting back to the fundamental purpose of this research, I seek to exemplify 
how organizations can frame and simplify strategic decision-making in a manner that 
becomes customizable and easily digestible across all cross-functions within the 
organization. While the complexities of such a shift often become a critical challenge for 
the management, simple frameworks can be shaped to avoid focusing on the content of 
the problem and instead understand the patterns in the underlying situation. By creating a 
visual aesthetic of organizational design, we have the ability to more clearly articulate the 
reasoning behind our decision-making. 
Robert Keidel has significantly influenced the simplified geometric approach that 
will be used to outline and frame the complex problems presented within this thesis. 
Keidel (2005) focused on expanding traditional mental models of limited strategic 
decision-making to reframe them into a combination of three weighted principals: 
control, autonomy, and collaboration. Keidel argued that human organization reflects 
cognitive organization.  
Using insights from Margret Wheathley’s Leadership and the New Science, 
Keidel’s triadic framework is grounded in the idea that similar to nature, organizations 
are combinations of relationships but with an added layer of intentional design to create a 
purposeful specification for those relationships. The triadic concept comes to fruition 





separate and autonomous with minimal contact – for instance, hierarchical in a boss–
subordinate arrangement or collaborative between the two parties. The design problem 
the framework aims to solve is how to best blend these interactions, which are inherently 
at odds with one another. 
Triangular design persists as a naturally constant pattern that allows organizations 
to balance and continually rebalance organizational structures across multiple functions. 
This mostly requires simultaneous tradeoffs between autonomy, control, and cooperation. 
By paying closer attention to thinking styles and patterns rather than the content, 
organizations can more clearly define and prioritize the focus of their strategies. The 
suggested framework therefore allows for a common language to help conceptualize an 









Management typically falters in three general ways when building an 
organizational strategy (Figure 3): 
Figure 3. Triangular Thinking  
Keidel, R. W. (2010). The geometry of strategy: Concepts for 






1. They may overprioritize one of the three organizational areas of focus, i.e., 
autonomy, control, or cooperation (one-variable design). 
2. They may focus minimally or not at all on the bottom priority (two-variable 
design). 
3. They may operate without any focus or priority (undifferentiated design). 
Keidel’s model challenges organizations to rethink and recommunicate a new 
system of thinking to focus on the three key elements of the triangular design, but it has 
several rules. First, every organization and unit within the organization should prioritize 
one of the three categories so that very specific and necessary tradeoffs are made. 
Second, each of these three variables should be appropriately integrated as essential and 
independent entities. Finally, the focus should be on the variables requiring attention at 
the given moment regardless of priority, and this should be adjusted over time as 
necessary (Keidel, 2005). 
5.1 Mental Models 
While the triadic framework will be the most effective scaffolding model for med 
tech’s management innovation, it is important to highlight the more traditional styles of 
thinking as these unconscious “geometries of thought” help us understand where we are 
today and may continue to serve a significant purpose with the correct application. Keidel 
has created a lens through which we can consciously determine which styles of thinking 
are needed in any given scenario or determine which decision can be moved into a 
different style of thinking (Table 1). Rather than define the answer, the questions we ask 





questions may inherently lead to a more triadic approach, which ultimately moves along a 











5.1.1 Point Thinking 
Framed within limited options, typically dichotomies, point thinking tends to 
reduce complex issues to binary tradeoff decisions with an either-or approach. Often, this 
can become an extremely limiting model, but it serves a clear purpose when defining an 
organization’s strategic persona. By clearly defining “who we are” or determining non-
negotiables, point thinking can become a powerful tool for clarifying not only how an 
organization will perceive itself but also how it will be perceived by the world. 
5.1.2 Linear Thinking 
Linear thinking, the next phase beyond point thinking, is linked to linear metrics 
such as cycle times, R&D spending, or profitability. These processes are linked to 
Table 1. Mental Models 
Keidel, R. W. (2005). Seeing organizational patterns: A new 







performance – or shades of grey. Keidel further broke down linear thinking into process, 
outcome, and legacy metrics, which are mostly necessary but often fail when 
benchmarking incorrect measurement criteria or inappropriately preparing for the future 
from a talent standpoint. 
5.1.3 Angular Thinking 
Angular thinking is rooted in the classic business school 2x2 strategic framework 
and focuses on both the black and white or the best of both worlds. The aim of the 2x2 
framework is to create options for complex issues, but it tends to ignore potentially 
important third variables in the equation. In most 2x2s, one of the quadrants 
mathematically becomes a non-desirable option ( -/- ), thus creating a triad of potential 
solutions (+/-, -/+, +/+). In identifying the areas where organizations can find value in 
best-of-both-worlds solutions, strategic decisions can move away from emphasizing one 
area over another and blend efforts into the most appropriate decision. 
The challenges with angular thinking, as described above, fail to account for a 
third option or variable in the equation. Here, the classic “prisoner’s dilemma” is a result 
of the lacking variables or, perhaps, misses the foresight in the potential failures of the 
best-of-both-worlds solution (+/+) by reverting to a somewhat point-thinking decision 
style by committing to a particular quadrant. While the 2x2 is certainly a well-established 
strategic framework, the lack of flexibility for both long- and short-term implications 
may be a blind spot as the framework behaves as more of a rigid mechanism as opposed 





5.1.4 Triangular Thinking 
The triadic approach seeks to explore larger patterns and, according to Keidel’s 
work, is considered to be more deeply based on how the organization itself is designed. 
Looking specifically at the strategies of competition (cooperation), growth (autonomy), 
and organization (control), the need to strike a balance on a weighted priority can be 
constantly shifted and adjusted based on changing environments or broken down into a 





Table 2. Common Triadic Thinking Frameworks  
Keidel, R. W. (2005). Seeing organizational patterns: A new theory 






The triangular approach encompasses the ability to evaluate competition, 
prioritize core competencies, and reimagine internal structures, or it may help reprioritize 
a company’s value chain (Figure 4). The simplicity of the design provides a perfect 
framework for facilitating medical device manufacturers’ transformation into med tech 
organizations, as these suggested frameworks are simply a reprioritization rather than an 
entire organizational overhaul. Most of the major players within the space already 
possess the resources and capacity to make such adjustments. The triadic framework is a 







Figure 4. Organizational Triad  
Keidel, R. W. (2005). Seeing organizational patterns: A new theory and 







5.2 Frameworks for Med Tech 
According to the paradox theory, no single or simple solution exists for the 
challenges faced by many organizations, and when in flux, the organization should 
address the uncertainty and seek to embrace the “both–and” (angular) solutions where 
appropriate (Jay, 2013; Lewis, 2000). The paradox theory allows for an alternative view 
through which organizations can accept these “both–and” strategies without the narrow 
constraints of a black-and-white “either/or” (point) approach to products and services 
(Smith at al., 2010). By broadening the horizon through which the related challenges are 
felt, organizations can implement better coping strategies for complex challenges 
(Dweck, 2006; Gupta & Govindarajan, 2002). 
The key to the paradox theory of servitization lies in the concept of embedded 
tensions between what is considered to be product logic and what is service logic, where 
the tension itself becomes an important asset in the equation but also establishes an 
either-or point-thinking approach. The tension, as noted, should not be seen through the 
lens of a tradeoff but rather as a mechanism for creating additional factors to help weigh 
decision-making and for making sense of an issue that seemingly holds two variables. 
Kowalkowski (2015) developed a third option as a potential trajectory within 
servitization to create a scenario where the areas of need can be weighed against one 
another, each important but likely prioritized according to the strategy and organizational 
environment. Taking a more angular view to servitization, we can expand the service and 
goods-dominant logic to a ‘best-and’ approach and thus better understand the paradoxical 





availability provider (autonomy), performance provider (cooperation), and industrializer 
(control); these can be applied to any new medical device service business. In this 
instance, we parallel availability with autonomy as a function of sales or local 
responsiveness, performance with cooperation as a means of cumulative learning or 
knowledge transfer, and industrializer with control to emphasize efficiency, consistency, 
or the process. In the context of the medical device industry, we are exploring 
servitization as the integration or re-conception of complex technology – such as 
robotics, artificial intelligence, imaging, or most outcome-driven systems – as the key 
value driver for the growing and competitive healthcare industry. 
“The new questions we have to ask ourselves are around what value we are 
specifically trying to create and exactly how are we going to do it. We cannot lose focus 
that digital solutions are products as well, don’t forget that.” – Vice President, Digital 
Strategy (Interview, October 2020) 
Paradoxes cannot be resolved; thus, organizations must create coping strategies 
for the weighted tensions between autonomy, coordination, and control. As the literature 
suggests, the key is to accept, appreciate, make sense of, and cope with the emerging 
concepts as opposed to choosing narrow paths or dismissing the tensions altogether 
(Beech et al., 2004). When attempting to create a coping environment to prepare medical 
device companies to accept the tensions from the product-to-service balance, a focus on 
both efficiency and effectiveness (angular) should drive the measurement and follow-up 
as well as reward the practices of the tensions between effectiveness and customization 





As device companies attempt to compete and differentiate, customized delivery 
methods and patient-impacting systems should, theoretically, negatively impact the initial 
standardization requirements and thus create a paradoxical tension between customary 
implant sales and service-rendered assistance or implementation. The tension between 
customization and efficiency becomes the clearest when device companies have an 
opportunity to innovate the current organizational frameworks. 
5.3 Systems Thinking Concepts 
“We don’t want to operate as an individual thirty-billion-dollar company. We 
want to operate as thirty individual billion-dollar companies.” – Geoff Martha, CEO 
Medtronic 
Substantial research and literature have been published on the failure of 
companies across all industries to anticipate or adapt to new markets or trends, which 
often results in missed opportunities for growth or, in many cases, complete collapse. As 
the healthcare ecosystem is in the early stages of significant change, many disruptive 
technologies and market demands will drive the blurred distinction between devices and 
their connected technology information systems as the need for connectivity between the 
two value drivers continues to grow.  
Systems thinking is a framework that strives to understand how various elements 
are connected to each other within a larger network of individual projects. The tensions 
present within the paradox of servitization extend to the medical device industry as a 





As mentioned previously, the value of the individual device begins to sink as a 
standalone item but significantly decreases as the device becomes integrated into a larger 
ecosystem of data-driven technology. Current systems of manufacturing or strategic 
technology acquisition tend to focus on black-and-white issues regarding individual 
solutions and individual problems, creating supply chains, quality systems, strategies, and 
sales agendas usually within silos. Some companies have the ability to offer a suite of 
value-added components, but the interconnectivity and data aspects of the value chain did 
not become significantly important until recently. 
Systems thinking takes a holistic approach that focuses on the interconnectivity of 
the linked assets within a larger system. Traditional value chains typically hold a more 
linear approach from end-to-end delivery, whereas systems thinking holds a variety of 
connectivity relative to the overarching goals of a program or organization, facilitating a 
unique way of managing and delivering simplicity through complex patterns. As opposed 
to a hierarchical control mechanism, systems thinking encourages both autonomy and 
cross-functional coordination by considering the structures of organizational patterns 
related to interactions and organizational dynamics as components of a larger structure at 
each level of the value chain; this helps anticipate, rather than react to, emerging 
challenges (Atun, 2012). 
Traditional hierarchal organizations tend to develop siloed, narrow-minded 
business functions, which, in turn, influence decision-making processes. Shifting to 
angular and triangular thinking requires accountability to strategy, technology, and 





organization without addressing the other two. Every complex organizational decision is 
invariably based on STO and requires frameworks to create options and direction with 
the intent of stimulating fresh thinking about organizational principles and choices. The 
design problem is how to best blend these alternatives (Keidel, 2010). 
A commercial leader of an orthopedic device manufacturer discussed the sales 
force as a component of the system: “We have to challenge ourselves as an organization 
around developing comfortability for our sales force around new technologies. It’s not 
just a change in customer behavior that we have to contend with, it’s also our own sales 
force that needs to change their learning and selling processes. As a leadership team 
we’ve realized that complex technologies don’t really fit the mold of our company, who 
we are, and the culture of our products. We’ve found that it’s not that customers don’t 
want our new technologies, it’s the field team that rejects the offering because of the 
complexity. We need to design solutions that are simple to use and understood across the 







6. Research Process 
The review will be an important component of the overall exploration of the 
posed questions; it will consider peer-reviewed sources on the subject matter, primarily 
systems thinking, servitization, cultural development, and sense-mapping. Among these, I 
will primarily focus on the idea of servitization, which refers to the business transition 
from a product-based business to a service-based one, both of which possess distinct 
organizational cultures and structures. 
The relevance of this topic is beginning to break ground in the medical device 
industry across all specialties for a variety of reasons, and it should be considered highly 
relevant by those familiar with the space. The thesis states that the industry will need time 
to adjust to these changes. The perspective I am offering is very likely to sound 
unfamiliar because it is a drastic divergence from the current way of life for both 
healthcare professionals and the industry. The veteran surgeon or career business leader, 
accustomed to working in one specific way, may take time to digest the partnership that 
accompanies the value-add of med tech. 
The fact that these thesis topics may take time to develop certainly does not come 
as a shock as I am aiming to influence how we treat patients in the future while 
understanding that change takes time and may suffer setbacks. The research I have done 
fits directly into the literature, specifically with regard to the culture and challenges of 
changing systemic thinking. When tied together, this perspective will allow medical 





gaps specific to med tech culture and recognizing the need for healthcare reform on 
multiple levels. 
I hope to fill the gaps associated with data-driven service business, which has yet 
to be described in a manner that looks at the value-add of the service rather than at the 
service as a means of production. My research will demonstrate the competitive 
advantage a medical device company can gain by appropriately focusing on the service 
portion of the new med tech aspect of their business and driving the culture away from 
implant manufacturing as a competitive advantage and differentiator. 
6.1 Design 
The epistemological viewpoints taken in this research have been highlighted in 
the introduction to depict the assumptions of an industry shift into service-oriented 
operations, even though it is a relatively new concept in the medical device industry. 
Using the literature review of the relevant topics associated with the subject matter expert 
interviews, this study adopted a conceptually exploratory strategy with qualitative 
characteristics to propose a strategic framework for the reader. 
I conducted structured interviews throughout the summer of 2020, approximately 
between July and September, to collect the relevant data. I used a questionnaire to 
determine the company’s journey to servitization through the eyes of different informants 
from business units in two regions. The questionnaire included questions about the 
definition and value proposition of the service offerings and the descriptions of their 





services. Afterward, content analysis, triangulation of the interviewees’ insights, and 
cross-case analysis were used to draw conclusions. 
The interview questions were designed to provide a background for the questions 
posed and create an open-ended atmosphere where I could gain insights that would not be 
influenced by my thesis statement. The specific samples for these questions were 
designed to create a variety of viewpoints, from the design to the surgical application. I 
hoped to pose questions for both current and future scenarios to better understand the 
road that a medical device leader may travel as well as the lens through which their 
business needs to function strategically in the future. 
A substantial amount of literature exists on the process of creating value through 
value-added services or through businesses pivoting their strategic focus to structure 
themselves as service-oriented businesses, but none are specific to the medical device 
industry in the context of culture, servitization, and systems thinking as opportunities for 
growth. In 1988, a paper written by Vandermewe and Rada, titled “Servitization of 
Business: Adding Value by Adding Services,” emerged as the foundation for the concept 
of servitization as a contextual opportunity. Later literature went on to reimagine the 
concept of servitization through terms such as bundling, product-driven systems, service 
packaging, and others, specifically for manufacturing companies; it also redefined the 
phrase as “going downstream” with customers as opposed to the traditional “upstream” 
product development (Cassia et al., 2015). To further draw a distinction, Wise and 
Baumgartner (1999) highlighted how the service value-add is primarily executed at the 





The problem to be solved is rooted in the cultural and structural organizational 
bottlenecks that will inhibit medical device companies from effectively competing in the 
quickly advancing healthcare space. Recent literature on the topic of servitization has 
expanded its scope to explore the implications of the process within organizations along 
with the structural challenges and best practices. One such area of focus is servitization 
through the concept of service-dominant (S-D) logic, as observed first by Vargo and 
Lusch (2004, 2008). The basis for this theoretical approach has guided the proposed 
solutions outlined within this paper and the continued development of med tech to 
embrace the outlined strategic concepts (Cassia et al., 2005): 
• Service is a fundamental basis of exchange. 
• Goods are a distribution mechanism for service provision. 
• The customer is always a co-creator of value. 
• An enterprise cannot deliver value, only offer value propositions. 
• Value is always uniquely and phenomenologically determined by the 
beneficiary. 
The findings of the literary review in conjunction with the triangulation of the 
subject matter expert interviews indicate a shift in value creation away from the 
manufacturer’s ability to produce new goods and into a realm where value is created and 
distributed through the customer experience during interaction with representatives and 
technology at the tail-end of the value chain. The conclusion of this research will address 





through custom and easy-to-understand methods, where the co-creation of value and user 
experience guides the focus of a firm’s strategic choices. 
I will function as an action researcher for this analysis. I hope this information 
will enable a company to strategically refocus its efforts and view its current landscape, 
both internal and external, through a new lens, providing some perspective on how to 
successfully compete in the healthcare industry. My hope is that the leadership will 
understand the impact of advances in med tech on outcome-driven data and clearly define 
where their company needs to fill gaps to deliver value for stakeholders in the future. The 
analysis considers the current lack of significant data pointing toward outcome 
improvement due to robotic interventions but also acknowledges the industry’s 
understanding that these technologies will continue to improve. Device manufacturers 
have been offered a new way to create value and compete through software and data. The 







7.1 Interview Strategy 
The research methods included observations and interviews with varying 
stakeholders across the med tech space. The observations included personal experience in 
building successful med tech clinical programs alongside hospitals and physicians across 
the United States and Europe as well as my internal corporate experiences working with 
both large and small medical device manufacturers. With regard to the emergence of 
robotics and AI in healthcare, I possess extensive experience due to both the infancy of 
the field and its narrow focus; in fact, I would consider myself a subject matter expert. 
Furthermore, I interviewed surgeons, physician assistants, hospital administration staff, 
device representatives, corporate leaders from successful med tech companies and major 
players stepping into the space, and general experts in med tech across multiple 
specialties, thus developing a well-rounded perspective on the subject matter. 
The interview method used in this study was based on the methodology for 
qualitative research specific to subject matter experts as described by Arena et al. (1991). 
The interviews collected data pertaining to the participants’ reactions to and experiences 
of the changing healthcare environment. They also explored the perceptions of how 
organizations and hospitals can participate in the paradigm shift to digital strategies. The 
interviews began by providing the subject matter experts with a context for the discussion 
to help create a sampling of the upcoming direction of the interview process. In each 
case, the participants were readily able to relate their personal experiences within the 





participate in the changing med tech environment. A few general questions were used to 
prompt the conversation’s validity regarding the changing needs in the healthcare 
landscape to create a sense of alignment, being mindful not to direct the participant’s 
opinions in any particular direction. The rest of the conversation involved obtaining their 
perceptions of the perceived changes needed and the unique challenges their own 
stakeholders will need to recognize. 
Using previously explored frameworks for perceived value creation (Wash et al., 
2014), the foundation for the interviews was built on the four fundamental dimensions of 
value: quality, emotional, price, and social. This framework was used to generate lines of 
questioning that would create an open space for participants to expand their thoughts with 
an open-ended reference to help connect past experiences with future possibilities. While 
the concepts of servitization were new to some of the participants, the questioning value 
framework allowed them to quickly build mental maps and further articulate their ideas. 
Throughout the interviews, the participants were encouraged to expand their 
participation and perceptions of digital technologies in medicine, which provided 
valuable cognitive data regarding their own sense-making of the proposed industry 
changes. The in-depth discussion about feelings, attitudes, and strategic challenges with 
each participant provided valuable insights that often conflicted with the varying 
viewpoints from the literature as well as other participants’ perceptions. The collected 
data suggests the clarity of the concepts described and the action steps needed maintain 






7.2 Interview Selection – Subject Matter Experts 
To add color and validation to the ongoing trends in healthcare, the research will 
engage in interviews with a variety of subject matter experts in the fields of both medical 
devices and med tech in order to gain experiential insight. Subject matter experts are 
defined as individuals with specialized experience or in-depth knowledge related to a 
subject; this is critical for successful technology adoption in healthcare. Furthermore, as 
defined by Suchman (1995), the interviewees were subjectively filtered to maintain 
pragmatic, moral, and cognitive legitimacy. The interviewed experts included a variety of 
individuals in businesses that have yet to engage with or adopt technology into their 
strategic focus as well as members of businesses related to culture and servitization but 
not healthcare. These divergent views created a space for discussion and engagement in 
an effort to challenge any bias the research may hold toward a particular plan of action. 
While subject matter experts should always be questioned with a significant level 
of challenge, emphasis was placed on the experiential component of the analysis with a 
greater level of acceptance, considering the limited number of subject matter experts in 
this field who have had the opportunity to execute successful strategies in the new med 
tech space. Less emphasis was placed on industry veterans who proved slow to adopt 
technology-driven strategies. Macdonald (1995) argued that organizational change must 
be dependent on new information coming from an outside source or agent, with 
challenges coming from internal acceptance and the credibility of the suggested changes. 
Macdonald claimed that many will be biased in favor of the “not-invented-here” 





research should accept new ideas or new ways of looking at problems and have the self-
awareness and vulnerability to embrace new perspectives. 
7.3 Findings 
The results of the interviews and literary reviews support the premise that 
significant managerial implications will ensue from the demand for a shift to service-
based frameworks as an alternative positioning strategy in the medical device industry. 
The thesis fundamentally argues that the transition to service has been quickly shifting 
device manufacturers away from product-focused arenas into an arena where experience-
oriented and outcome-oriented services will drive multiple levers of value in the 
healthcare industry. The interviews indicated some of the needs to capitalize on these 
shifts, spanning from survival to market leadership, but the concept that the business 
must build frameworks and processes remained consistent across the participants. 
Regarding the research conducted on the transition into service business, the 
interviews aligned with the common understanding that such a fundamental shift in the 
business poses challenges beyond the framework and execution and within the culture 






8. Systems Thinking Models 
8.1 Service as Co-Creation 
 Vandermerwe and Rada (1998) frame servitization as an organizational change 
process via which new streams of revenue are generated through the provision of services 
associated with a firm’s traditional goods. As medical device manufacturers move toward 
servitization, there is a decline in the linear thinking concept of goods-dominant (G-D) 
logic, both strategically and in application. In G-D logic, the value output is 
manufactured by the firm and distributed to the market, where the roles of producers and 
consumers are fairly distinct. As firms move toward servitization, there is a need for an 
alternative strategy of value creation that is built in S-D logic. The roles of producers and 
consumers will become much less distinct, meaning the input and output data necessary 
for value creation requires the integration of resources and competencies to deliver 
smarter and more customized solutions in the med tech space. 
The process of servitization aims to collaboratively create value via mutual 
exchange, while the concept of service systems is centered around the triad of 
participants, processes, and resources, which interact to deliver outputs (Vargo et al., 
2008). A service system’s function is to make use of its own resources and those of 
others to improve its own and others’ circumstances (Spohrer et al., 2008). Current 
medical device practices focused on production processes aim to deliver goods, where the 
pricing strategies deliver value based on the company’s market position. Conceptually, 
maximum efficiency leads to maximized profitability. In such scenarios, standardization 





Servitization will fundamentally challenge these general manufacturing foundations as 
economies of scale and efficiencies become notably less critical factors from an output 
standpoint. This is because the co-creation of value is now delivered through customized 
user experiences, making customer input a new aspect of the value creation equation. 
According to Vargo et al. (2006), when goods are involved, they are tools for delivery 
and application of resources. 
The servitization shift from G-D logic to S-D logic demands a change in the basis 
of exchange. While manufacturers using G-D rely on the exchange of goods as value, S-
D logic creates value through the co-creation and exchange of knowledge and skills. 
Through this lens, co-creation through the combined efforts of firms, employees, 
customers, governments, third-party organizations, and any other entity can be 
customized and determined by the beneficiary, or the customer, of the transaction. 
According to Vargo and Lusch, “There is no value until the offering is used—experience 
and perception are essential to value determination” (2006, p. 44). Alternatively, as noted 
earlier, we can equate this statement to a focus on customer satisfaction as we connect it 
specifically with the needs of med tech. 
The medical device industry demands customized solutions via digital 
experiences, robotic integration, and value propositions based on both clinical and 
economic needs. The concept of co-creation remains attractive as we look at these 
opportunities within the area of solutions (outputs) relative to specific user needs (inputs). 
As Beinhocker (2006) outlined in an HBS Press article, the value depends on the 





Appropriately utilizing the service system of an outside subsystem would mean 
incorporating improved capabilities. Thus, “value-in-use can be defined as a system 
improvement within a particular environment” (Beinhocker, 2006). 
 
  
G-D Logic S-D Logic
Value Driver Value-in-exchange Value-in-use or value-in-context
Creator of Value
Firm, often with input from firms in a supply 
chain
Firm, network partners, and customers
Prcoess of Value Creation
Firms embed value in "goods" or "services", value 
is 'added' by enhancing or increasing attributes, 
product innovation
Firms propose value through market offerings, 
customers contineu value-creation process through 
use, customized system solutions and experience
Purpose of Value Increase wealth for the firm
Increase adaptability, survivability, and system 
connectivity through service (applied knowledge and 
skills) of others
Measurement of Value
Amount of nominal value, price received in 
exchange
The adaptabilty and survivability of the beneficiary 
system
Resources Used Primarily operational resources
Primarily operant resources, sometimes transferred by 
embedding them in operend resource-goods
Role of Firm Prodcue and distribute Value Propose and co-create value, provide service
Role of Goods Units of output, priced to embed value
Vehicle for operant resources, enables access to 
benefits of firm competences
Role of Customers To 'use up' or 'destroy' value created by the firm
Co-Create value through the integration of firm-




Table 3. Goods Dominant Logic via Servitization 
Vargo, S. L., & Lusch, R. F. (2006). Service-dominant logic: What it is, what it 
is not, what it might be. In The service-dominant logic of marketing: Dialog, 






9. Performance Culture  
“Success is not about launching the perfect technology but rather, are we driving 
the right culture to change?” – Vice President, Digital Strategy (Interview, October 2020) 
9.1 How to Compete 
A majority of this analysis has driven the idea of service as a competitive 
differentiator focused on customer experience and satisfaction, along with the underlying 
causation of improved outcomes and more efficient surgical experiences. Though the 
shift to service at a systems organizational level may present unique challenges, the 
medical device space presents itself as a uniquely positioned field due to many of the 
current corporate structures relying on a service-like representation and customer 
relationships to drive business. Purely from a manufacturing standpoint, organizations 
will need to look beyond these established norms and create a systematic approach 
throughout their value chain to ensure that a sustainable competitive advantage is 
thoroughly adopted and established. 
McKinsey laid out an argument (Chadha and Llewellyn, 2019) for the pure value 
play in medical devices, arguing that there is a growing demand for “good enough” 
products that are competitively priced and, for the purposes of our analysis, 
commoditized. With the med tech sector growing, slow adaptors and laggards will 
continue to play a role within the customer pipeline, especially in the international 
landscape. Identifying this area of basic competition is important because it inherently 








The “basic” segment of the market in the above graph has a direct correlation with 
the maturing commoditized segments of medical devices; many of the implants and 
instruments were previously referenced as common use and requiring minimal 
innovation. These products are typically offered to value-oriented customers who tend to 
adopt innovation slowly or perhaps operate in an environment with a highly cost-
conscious balance sheet. These environments often have little room for premium 
offerings regardless of the clinical advantage or benefits that a new and innovative 
technology may be able to bring to the organization. The products in the basic category 
typically offer minimal service and compete purely on the basis of price. 
The “premium differentiated” quadrant is the area where med tech makes the 
highest impact (Figure 6). Here, it can introduce highly sophisticated digital and 
software-based solutions that help drive outcomes and efficiencies but are not necessarily 
specific to any implantable devices where profit margins are made. The products and 
Figure 5. Premium Differentiated 2x2 
Chadha, S., & Llewellyn, C. (2019, June 5). Solutions and services in medical 






services in this quadrant tend to focus on outcomes and efficiencies and are supported by 
service models with frequent touchpoints with company representation. While these 
premium offerings can command higher price points in terms of compatibility with 
integrated implant systems, the general business model around new digital offerings is 




Regarding the scope of med tech as an area ripe for innovation through 
servitization, the above framework (Figure 7) is an example of the ways in which device 
companies can begin to reprioritize areas of the business where competencies need to be 
established and resources may be reallocated. From a strategic standpoint, the 
aforementioned example allows for a simplified way to weigh current standards with 
future directions and develop clearer decisions at each level of the value chain. Each level 
may require its own strategic framework built on the shifting focus of larger 
organizational initiatives. 






In the example below (Table 4), I use the model built in 2013’s Ten Types of 
Innovation: The Building Blocks of Breakthroughs (Euchner, 2014) to address the areas 
of experience that help frame the shift to service in med tech, where customer satisfaction 
is a key area of value. The provided linear framework may help organizations better 
understand the current versus future competencies that need to be reprioritized to 





Table 4. Ten Types of Innovation 
Euchner, J. (2014). Ten Types of Innovation: The Discipline of Building 






10. Organizational Structure 
 “How will technology change the way we create value? It’s not necessarily 
entirely clear. The hardest thing we’ll face is our business’ lack of a big return at the start. 
How we collect data and turn the information into actionable insights will take time to 
generate. As a leadership team, we must remain patient and financially disciplined.” – 
Vice President, Digital Strategy (Interview, November 2020) 
10.1 Value Chain 
When I spoke to an orthopedic product director about customer satisfaction, it 
quickly became clear that the need for differentiation will always remain relevant but be 
increasingly harder to rely on in the current environment: “From a pure product 
perspective, we’ve differentiated by creating options for surgeons. If you look across our 
or our competitor’s portfolios, we’ll generally have similar offerings, but each company 
has a few little things that the others don’t. I think for our newest product launches we’ve 
focused on providing as many options as possible which eliminates the anxiety before the 
procedure. In a lot of ways, the customer satisfaction comes through the lowered anxiety 
before the case – not during or after – because our customers know they’ll have 
everything they need heading into surgery.” (Interview, July 2020). 
The aforementioned insight blends well with the direction that the med tech 
industry is taking, as preoperative analysis and decision-making are important pieces of 
the puzzle that healthcare will continue to solve. Point thinking may create a dichotomy, 
implying that organizations are either manufacturers or med tech companies. Both 





a scaffolding that can allow organizations to weigh and prioritize the necessary aspects of 
control, autonomy, and cooperation required to make the most efficient transition. 
Essentially, manufacturers currently hold a heavy upstream focus on control as they pour 
resources into product offerings and iterative development around manufacturing and 
engineering efforts. Conversely, the downstream customer interaction in the operating 
room tends to be more of an autonomous interaction as sales representatives rely heavily 
on relationships and customers retain satisfaction through complete portfolio offerings, 
only to use those instruments and products as they see fit. 
The introduction of product service systems as the collaborative arm of value 
chain innovation allows manufacturers to emphasize the combination of product and 
service. From a structural standpoint, the ability to create new categories of responsibility 
serving cross-functional needs has created clearer synergies and a more impactful 
adoption curve for several subject matter experts who are currently successfully 
implementing digital technologies in traditional business models:  
“We’ve look at our training team as part of the commercial sales organization as 
opposed to being a component of the operational side of the business, we see ourselves as 
the ‘secret sales force.’ We gain the most customer satisfaction through our reps who 
manage our robots, we hear it all the time from our surgeons. What makes the difference 
is the people and the support and our surgeons need to completely rely on the 
competency of our team, our people have a level of expertise that our competitors do not. 
There’s a huge opportunity for traditional manufacturers to disrupt the industry from an 





Additionally, multiple subject matter experts mentioned similar new categories 
with cross-functional responsibility to evolve away from the traditional hierarchical 
model. Often, they mentioned how these positions facilitated a much clearer feedback 
loop for the business: “We created a new layer between marketing and sales responsible 
for strategy creation, content marketing, and a capital sales quota. It’s allowed our 
business to be informed on a much clearer level by creating a new layer between our 
internal and external teams. People want to experience a ‘buyer’s journey,’ and this 
added layer helps our business understand where our customer’s needs and desires 
already exists. From there, we create a story around our offering.” – Director of Growth, 
Med Tech (Interview, November 2020) 
Building a new organizational structure to manage the requirements of a new 
digital servitization strategy has been a point of tension for companies that have acquired 
and implemented such programs. A part of the long-term executive vision and support 
allows for these challenges to be met with acceptance and, in some instances, may lead to 
a misunderstanding of the level of competency required to manage the newly acquired 
technology. As noted by Bustinza et al. (2015), “service innovation requires 
comprehensive organizational transformation.” 
10.2 Relational Governance 
I have outlined the need for a paradigm shift at the point of care for device 
manufacturers as competitive advantage is currently gained at the end of the value chain, 
where surgeons interact with finished goods and company representation. Furthermore, as 





solutions beyond the operating room and through the patient’s journey of care. 
Reiterating the discussion from Section 10.1 that specifically examines the current value 
chain, the work of Chatterji et al. (2015) focuses directly on sales force strategies in the 
U.S. medical device industry and the implications of launching innovations into new 
markets. They found that the concept of relational capital allows organizations to 
facilitate economic exchange and relationship development with outside partners over 
time through knowledge transfer, resource investment, and coordinated activities. It also 
impacts boundary decisions as product portfolios and market demands change. Thus, 
Chatterji et al. (2015) ask questions about the effects of preexisting relationships between 
firms’ impacts on future decisions to integrate sales activities as product portfolios 
evolve. 
In this example, relational capital is comprised of three main elements: shared 
trust (cooperation), routines (control), and norms (autonomy). The repeated exchange of 
these elements among groups helps develop interfirm relationships, the core of which 
creates coordinated activity, behavior management, and structured facilitation in the 
absence of a centralized process. As organizations improve relational governance with 
outside firms, the market for innovation should evolve as well, but this can be impacted 
by the shift to a “sell-first” mentality that the digital component of med tech demands. 
This is particularly evident in areas where manufacturers work with sales distributor 
firms or other third-party external organizations. 
“Education has to become a part of the commercial business strategy, not a 





partners who’ve used their acquired expertise to fuel earning potential and use the 
technology as a driver that leads to other products.” – Training Director, Robotics 
(Interview, November 2020) 
In terms of how organizations can evolve to prepare for the servitization shift, the 
training pipeline is an example of an area ripe for innovation – from both commercial and 
structural standpoints – that has the opportunity to make a significant impact.  
“Be a disrupter internally, not just through the product. It’s a people-first 
mentality at all times. Larger firms can learn a lot from some of these smaller startup 
companies when it comes to utilizing training with the commercial side of the business. 
Innovation is really hard, especially with robotics, software, and all the non-traditional 
tools the market is asking surgeons to adopt. People and expertise will make up the 
difference where the product is lacking – add more resources to your people. Let the 
training teams drive the culture and lead the change.” – Training Director, Robotics 






11. Innovating Med Tech Models 
11.1 Persona: Hardware to Software  
The concept of point thinking holds its own limitations but plays a significant role 
where organizations can commit to a persona and culture to shape the future of its 
business. Throughout this research, I have reviewed the strategies and challenges utilized 
and faced, respectively, by medical device manufacturers in the face of the growing need 
to shift to a med tech company. Here lies a great opportunity to take advantage of the 
industry-driven dichotomy and commit to an identity shift where organizational culture 
will play a critical role in how organizations attract talent and shape business offerings to 
align with a clear vision. 
The commitment to “med tech” signals to the cross-functional stakeholders a 
change in attitude and beliefs. These signals are becoming growingly critical throughout 
the hierarchy of the leadership chain, as interviews with subject matter experts have 
outlined the critical role a top-driven approach plays when building new business models. 
The role leadership plays in the shift to digital sets the tone for the organization’s cultural 
commitment to the future of healthcare; moreover, its implications are felt in the 
investment strategies and management structures. 
New business models will fundamentally alter the way traditional manufacturers 
operate financially, so accepting change and remaining agile will continue to require 
significant top-level support to remain committed to a longer-term vision. Organizations 
will face challenges in shifting their persona without the support of leadership with 





standard leaders to misjudge or develop a misguided understanding of the commitment 
needed to evolve the business. 
An additional component plays a significant role when looking at organizational 
structures in the context of the internal or external functional dichotomies that many 
organizations possess. While this view may not be specific to the medical device 
industry, organizational structure can play a key role in the necessary feedback loop that 
manufacturers will need as they shift to a digital and servitized value chain. The 
suggested model does not point to a new way of thinking about the internal or external 
dichotomy; instead, it challenges organizations to completely eliminate such mental 
frameworks through restructuring. While certain functions may certainly remain 
primarily focused inward (R&D) and others may consistently remain customer-facing 
(sales), the value chain should evolve in a way that is driven by new roles having cross-
functional responsibilities as the new go-betweens for these separate business units. The 
constant feedback loop should allow for more consistency regarding clear and timely 
decision-making about market initiatives and potentially make a meaningful impact on 
point-of-care customer satisfaction. 
11.2 Measuring Opportunities 
The way in which med tech companies measure success and opportunities on a 
linear scale is one of the more meaningful business model shifts that the interviews have 
uncovered. The acceptance of short-term loss or slow adoption rates are common themes 
among many of the subject matter experts’ questions regarding the topic, each of which 





abundantly clear that future business models based on data collection and utilization are 
going to be one of the most important changes in the industry, but the revenue models 
and relationship with payers remain unclear. Nonetheless, the vision of the med tech 
space has a persona. However, the existing mental models on the linear nature of 
measuring success may require a paradigm shift. 
“Looking at our M&A strategies to acquire new technologies we typically focus 
on incremental revenue for any given project. Here is where we’ll need the biggest 
financial culture change and the most strategic alignment. We have to learn that digital 
surgery in many ways is more about revenue downside protection as opposed to upside 
opportunity to gain share. Revenue loss avoidance is not traditionally in our base case 
financial models. How do we measure productivity gains? How do we quantify value? 
Although these digital investments may take time to come to fruition, they create 
disadvantages for our competition, have the opportunities to reduce our costs elsewhere 
in the value chain, and allow us to improve customer loyalty.” – Vice President, Digital 
Solutions (Interview, September 2020) 
With a systems thinking approach, looking at the independent project’s expected 
net present value (eNPV) may require a shift in approach as the interconnectivity of the 
integrated parts will be much more valuable as an ecosystem. Having the ability to tie in 
multiple projects to a larger system, eNPV may serve as an appropriate shift when 
improving switching costs and data collection. These can then become valuable drivers of 





recognizing a new way to measure both opportunities and success in a linear framework 
poses a new challenge for business leaders intending to create a financial paradigm shift. 
11.3 Challenging Organizational Norms  
The “Icarus paradox” or “paradox of performance” refers to an organizational 
tension focused on a company’s past successes as the main factor in the persistence of a 
strategic action plan that focuses on old strategies. In other words, businesses often fail 
after periods of abrupt success when they simply follow the same pathways that 
facilitated the initial success. For instance, only 19 of the Fortune 100 companies in 1966 
are still on the list today. As Miller (1990) explained, success can lead to converging 
ideologies; this eliminates awareness and the important forces of tension and divergence 
and creates a defensive mindset regarding those who have relied on past success. 
The process of challenging organizational norms impacts the mechanism of top-
down hierarchical control and seeks to structure complex problems as puzzles with a 
blend of alternative options. Angular and triangular cognitive methods help balance 
organizational control with additional autonomy and coordination in an effort to create 
common languages and simplify complex issues. The move toward angular and triangular 
frameworks provides an avenue to connect high-level organizational principles with 
industry- or function-specific knowledge, allowing thinking patterns and decision-making 
to become richer and more inclusive (Keidel, 2010). 
Both similarity and difference are rooted in autonomy, control, and coordination, 
allowing triangular patterns to form in ways that clarify a variety of concepts or blended 





beyond point and linear cognitive methods becomes apparent when medical device 
manufacturers continue to add new layers of complexity to their environment both 
internally and externally. 
11.4 New Layers – Systems Thinking Structures 
“Positions with both internal and external responsibility are the people who not 
only understand the problems from both sides of the business but also know how to solve 
them.” – Director of Growth, Med Tech (Interview, October 2020) 
The biggest opportunities to innovate from a structural perspective lie within the 
cross-functional responsibilities rooted in a systems thinking approach. Many of today’s 
corporate structures operate within a hierarchical framework and tend to reflect these 
linear themes upon evaluation of the traditional value chain. In many ways, medical 
device companies are reflective of the same customary conservative healthcare industry 
standards, and as we shift to servitization, they may struggle to adjust to the quickly 
changing environment of digital surgery. From the dichotomies of functional roles 
(marketing versus R&D) to stack-ranking eNPV projects to allocate capital, adding third 
dimensions between business units presents an opportunity to reshape how a business 
interacts cross-functionally. In an effort to begin the process of creating a systems-
focused organization. While every organization will be different, the concept of adding 
additional layers to link functions becomes an important piece of systems development. 
New organizational layers eliminate the traditional linear approach and facilitate 
feedback loops between cross-functional units, creating a communication system with the 





internal–external dichotomies, certain functions also play a role in becoming essential 
components of the new business design. The key to effectively implementing these 
additional layers is that the new leadership positions hold significant responsibility and 
hyper focus on coordination between the functional units. 
Typical marketers tend to be engineers, salespeople, or pure marketers and as an 
example, a director of ‘growth’ may bear responsibility for both sales and marketing. By 
adding a capital sales quota, we create a formula to help improve the product’s story, 
better understand forecasting, and enabling us to understand the customer’s journey more 
clearly to effectively build partnerships. In another example looking at the responsibilities 
for a director of training, the training team is not typically brought into the commercial 
business as a critical aspect of the sales journey. Setting customer expectations, gaining 
critical feedback, and subject matter expertise help bridge the gap with R&D in a much 
more efficient manner and seemingly eliminate the internal or external dichotomy.  In 
this training example, the cross responsibility to both sales and R&D becomes critical to 
servitization. Finally, a director of ‘user experience’ may play a role as marketer, 
understanding the product through the eyes of the customer, and understands market 
needs while simultaneously playing a role critical to the R&D team, working directly 
with engineers to create realistic products with more efficiency. As a function of nature, 
these new layers create additional triads where middle managers can operate with a 
clearer feedback loop. Some of these functions may shift depending on the organization, 
but the central idea is that a much clearer systems approach is being created as we add 





Because these feedback loops create a systems thinking organization, managing 
projects throughout an ongoing life cycle significantly changes through enhanced 
collaboration. These structures can also impact eNPV, which will dictate project 
prioritization. While the feedback loop is constant and efficient, the business can more 
critically evaluate the whole interconnected program which inherently becomes an 
important aspect of digital business within healthcare. Furthermore, the concept of 
servitization becomes an embedded aspect of the organization as these layers are 
integrated into the feedback loop of the business. This helps shift the culture toward a 
user-experience with an enhanced focus on patient outcomes and system improvement.  
11.5 Final Thoughts: Finding Triads 
The emphasis of this paper outlines the need for an expansion of the current 
mental frameworks focused around linear and angular thinking and adds the component 
of service (cooperation) to the already established roles of provider (autonomy) and 
technology (control) to more clearly frame the challanges of servitzation.  By using the 
triadic framework where possible, med tech organizations will have the ability to more 
clearly focus time and resources in areas of need and better understand the complexities 
of both internal and external factors that will impact a quickly growing technology 
market. 
This research taps into a broad spectrum of opportunities for medical device 
manufacturers to rethink and reshape their organizational abilities to better serve the 
needs of a fast-changing industry. The highlighted information has sought to answer 





prioritization of systems thinking approaches. While these questions may remain 
uniquely positioned for each business to answer on their own, I have built a strategic 
framework to help facilitate the process. Much of the existing research points to the need 
for structural changes, expanding mental models, and most importantly, recognizing the 
need for constant change. 
As we stand today, surgeons and other healthcare providers know manufacturers 
and their products very well, which bestows on them subject matter expertise and control 
over clinical decisions and execution. New technology seemingly places this expertise in 
the manufacturer’s hands instead, giving a business more control over its position in the 
market as well as interactions with customers. Considering the power of knowledge, one 
of the biggest and most important aspects of med tech companies will prove to be the 
level of training and development as both a means to create value and improve customer 
satisfaction. The suggested structural changes will provide valuable frameworks to 
implement these ideas, which will then trickle down to impact the culture, time to market, 
and communication. They will also create businesses that can partner with providers in a 
way that improves the lives of people around the world. 
Further research can be done to better evaluate the impact of servitization in 
specific healthcare sectors, including telehealth and pharmaceuticals. While this analysis 
was a first look at the newly emerging and growing needs of med tech, its successes and 
failures will certainly help guide more specific research as we evaluate the impact on 
culture and the overall effect providers experience as decision-making continues to 





adoption of software-enabled decision-making and how these changes can impact the 
cost of care. Finally, research can further explore how the shift to servitization impacts 
the medical sales world. One can assume that the sales professional will also need to 
adjust and become more of an SME in terms of technology and processes as opposed to 
products or devices. These impacts will drive the way manufacturers interact and form 
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